[HTML][HTML] A systematic review of computational approaches to understand cancer biology for informed drug repurposing

F Ahmed, A Samantasinghar, AM Soomro, S Kim… - Journal of Biomedical …, 2023 - Elsevier
Cancer is the second leading cause of death globally, trailing only heart disease. In the
United States alone, 1.9 million new cancer cases and 609,360 deaths were recorded for …

From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies

A Mukherjee, S Abraham, A Singh, S Balaji… - Molecular …, 2024 - Springer
In the dynamic landscape of targeted therapeutics, drug discovery has pivoted towards
understanding underlying disease mechanisms, placing a strong emphasis on molecular …

[HTML][HTML] Anticancer effect of Moringa oleifera leaves extract against lung cancer cell line via induction of apoptosis

K Bhadresha, V Thakore, J Brahmbhatt… - Advances in Cancer …, 2022 - Elsevier
Since ancient times, Moringa oleifera has been a common vegetable in many nations. It has
a large number of phenolic compounds with a diverse range of biological activity. It has …

Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy

X Liao, M Ozcan, M Shi, W Kim, H Jin, X Li… - …, 2023 - academic.oup.com
Motivation Many approaches in systems biology have been applied in drug repositioning
due to the increased availability of the omics data and computational biology tools. Using a …

Refining breast cancer biomarker discovery and drug targeting through an advanced data-driven approach

M Rakhshaninejad, M Fathian, R Shirkoohi… - BMC …, 2024 - Springer
Breast cancer remains a major public health challenge worldwide. The identification of
accurate biomarkers is critical for the early detection and effective treatment of breast cancer …

[HTML][HTML] SLC2A1 boosts the resistance of non-small cell lung cancer to taxanes by stimulating the formation of EPCAM+ cancer stem-like cells via glycolysis

Z Yu, J Sun, K Fang, J Xu, J Yang, D Chunlei… - Translational …, 2024 - Elsevier
Background The mechanisms by which SLC2A1 enhances chemo-resistance of taxanes to
non-small cell lung cancer (NSCLC) remains enigmatic. Methods An investigation into the …

Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer

JE Faya Castillo, RJ Zapata Dongo, PA Wong Chero… - Plos one, 2024 - journals.plos.org
Non-small cell lung cancer (NSCLC) is a type of lung cancer associated with translocation of
the EML4 and ALK genes on the short arm of chromosome 2. This leads to the development …

Unraveling new avenues in pancreatic cancer treatment: A comprehensive exploration of drug repurposing using transcriptomic data

N Sunildutt, F Ahmed, ARC Salih, HC Kim… - Computers in Biology …, 2025 - Elsevier
Pancreatic cancer, a malignancy notorious for its late-stage diagnosis and low patient
survival rates, remains a formidable global health challenge. The currently available FDA …

Association between cumulative exposure periods of flupentixol or any antipsychotics and risk of lung cancer

Y Chai, RYK Chu, Y Hu, ICH Lam, FWT Cheng… - Communications …, 2023 - nature.com
Background Preclinical evidence suggests that certain antipsychotic medications may inhibit
the development of lung cancer. This study aims to investigate the association between …

Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations

M Abutalebi, D Li, W Ahmad, K Mokhtari… - International Journal of …, 2024 - Elsevier
Colorectal cancer (CRC) is a major worldwide health issue, with high rates of both
occurrence and mortality. Dysregulation of the transforming growth factor-beta (TGF-β) …